slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 39,121-39,150
Pages 3,683
Rows per page 30
Component
39,121-39,150 of 110,471
13
The slide uses a pie chart to illustrate R&D investment allocation and a list-based framework for commercial investment priorities.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction2 hits
23
The slide uses a split-screen comparison of two distinct clinical trial datasets.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations 2 hits
24
Includes footnotes defining abbreviations and trial details.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations 2 hits
17
The slide uses a timeline diagram to illustrate the clinical trial flow and two boxes to detail study design and operational status.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 2 hits
21
The slide uses a vertical process flow to map clinical development stages to specific de-risking outcomes.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 2 hits
06
Azek | Results Presentation Deck | 20 slidesAzek | Results Presentation Deck | 20 slides · The AZEK Company
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction2 hits
07
Slide 7 of a presentation deck.Azek | Results Presentation Deck | 20 slides · The AZEK Company
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction2 hits
10
The slide uses a side-by-side comparison table structure to contrast two business segments.Azek | Results Presentation Deck | 20 slides · The AZEK Company
Conference presentation Investor relations Beat · DevelopmentLoop · So What Cascade2 hits
12
The table tracks various operational and market factors, noting whether the outlook is consistent with previous quarters.Azek | Results Presentation Deck | 20 slides · The AZEK Company
Conference presentation Investor relations Beat · DevelopmentLoop · So What Cascade2 hits
14
The slide uses two waterfall charts to explain EBITDA variance. The left chart focuses on the 1Q22-1Q23 period, while the right chart focuses on the FY2022-FY2023 period.Azek | Results Presentation Deck | 20 slides · The AZEK Company
Conference presentation Investor relations Beat · How2 hits
25
The slide uses a comparative structure to highlight engagement metrics (time spent) and scale (game count, portals, audience).Azerion | Investor Presentation Deck | 45 slides · Azerion
Pitch deck Investor relations 2 hits
40
Strategy deep dive context; mentions NFT sales impact in prior year.Azerion | Investor Presentation Deck | 45 slides · Azerion
Pitch deck Investor relations Beat · Financials2 hits
42
Includes a table row for Gross profit margin at the bottom of the EBITDA chart section.Azerion | Investor Presentation Deck | 45 slides · Azerion
Pitch deck Investor relations Beat · Financials2 hits
23
The slide uses a numbered list format to outline corporate strategy.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction2 hits
12
The slide uses a split-layout: left side defines the disease burden and market opportunity, right side defines the drug mechanism and target patient population.BenevolentAI | Investor Conference Presentation Deck | 17 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet2 hits
07
The slide uses a process-flow style to connect seed innovation to end-product benefits.Benson Hill | Results Presentation Deck | 24 slides · Benson Hill
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
08
Benson Hill | Results Presentation Deck | 24 slidesBenson Hill | Results Presentation Deck | 24 slides · Benson Hill
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
47
Uses Venn-style diagrams to represent TAM/SAM relationships.Berkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations Beat · Satisfaction2 hits
50
The chart uses a stacked area representation to show historical waves of innovation.Berkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations Beat · Satisfaction2 hits
76
Product specification and go-to-market summary slide.Berkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet2 hits
77
The slide uses a vertical process flow to show progression from current state to future product launch.Berkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet2 hits
78
The slide uses a bulleted list structure to define strategic pillars for M&A.Berkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet2 hits
09
The slide uses a structured list format to contrast the specific opportunity in UPS with the broader landscape of other sarcoma subtypes.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations Beat · Market Size2 hits
15
The slide uses a 2x2 grid of metrics to frame the market opportunity, followed by specific target population and success threshold data.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet2 hits
22
The slide uses a grid of metrics to define the addressable market and clinical success thresholds.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations 2 hits
25
The chart displays longitudinal data for two specific patients, showing sustained complete response.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations 2 hits
26
The slide uses a combination of big numbers and bulleted lists to frame the market opportunity and clinical unmet need.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations 2 hits
28
The slide uses a process-flow layout to describe clinical trial progression.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations 2 hits
31
The slide uses a timeline-based visualization to show dose escalation steps. RP2D = Recommended Phase 2 Dose. DLT = Dose Limiting Toxicity.BioAtla | Investor Presentation Deck | 40 slides · BioAtla
Pitch deck Investor relations 2 hits
03
Canada Goose | Investor Presentation Deck | 28 slidesCanada Goose | Investor Presentation Deck | 28 slides · Canada Goose
Pitch deck Investor relations Loop · Why Now2 hits